Stephan Krause
Executive Director, Analytical Science , Technology & Cell Therapy Quality Bristol Myers Squibb
Seminars
Tuesday 15th September 2026
Panel Discussion: Weighing the Pros & Cons of Automated Manufacturing
9:30 am
- Exploring the adoption of automated manufacturing process to enhance consistency, output and decrease variability
- Examining integration and flexibility challenges in automation to inform realistic implementation strategies
- Analyzing the impact of automation on cost of goods to optimize resource allocation and support sustainable clinical and commercial manufacturing
Thursday 17th September 2026
Defining Phase-Appropriate Control Strategies for Diverse Cell Therapy Products
11:25 am
- Exploring how phase-appropriate control strategies differ across CAR-T products, to ensure fit-for-purpose development strategies
- Evaluating potency and functional assays tailored to each modality to guide safe and effective transition from first-in-human through later clinical phases
- Discussing the evolution of control strategies from FIH to BLA to establish regulatory confidence
- Considerations for post-license control strategy revisions
